| Exosomes: from garbage bins to promising therapeutic targets M H. Rashed, E Bayraktar, G K. Helal, MF Abd-Ellah, P Amero, ... International journal of molecular sciences 18 (3), 538, 2017 | 464 | 2017 |
| Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet GM Raso, R Simeoli, A Iacono, A Santoro, P Amero, O Paciello, R Russo, ... The Journal of nutritional biochemistry 25 (1), 81-90, 2014 | 94 | 2014 |
| Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer M Pichler, C Rodriguez-Aguayo, SY Nam, MP Dragomir, R Bayraktar, ... Gut 69 (10), 1818-1831, 2020 | 87 | 2020 |
| Polychlorinated biphenyls (PCB 101, PCB 153 and PCB 180) alter leptin signaling and lipid metabolism in differentiated 3T3-L1 adipocytes MC Ferrante, P Amero, A Santoro, A Monnolo, R Simeoli, F Di Guida, ... Toxicology and applied pharmacology 279 (3), 401-408, 2014 | 71 | 2014 |
| Understanding the role of the gut microbiome in gastrointestinal cancer: A review D Ağagündüz, E Cocozza, Ö Cemali, AD Bayazıt, MF Nanì, I Cerqua, ... Frontiers in pharmacology 14, 1130562, 2023 | 64 | 2023 |
| Therapeutic targeting of AXL receptor tyrosine kinase inhibits tumor growth and intraperitoneal metastasis in ovarian cancer models P Kanlikilicer, B Ozpolat, B Aslan, R Bayraktar, N Gurbuz, ... Molecular Therapy-Nucleic Acids 9, 251-262, 2017 | 62 | 2017 |
| Effects of non-dioxin-like polychlorinated biphenyl congeners (PCB 101, PCB 153 and PCB 180) alone or mixed on J774A. 1 macrophage cell line: modification of apoptotic pathway MC Ferrante, GM Raso, E Esposito, G Bianco, A Iacono, MT Clausi, ... Toxicology letters 202 (1), 61-68, 2011 | 51 | 2011 |
| Conversion of RNA aptamer into modified DNA aptamers provides for prolonged stability and enhanced antitumor activity P Amero, GLR Lokesh, RR Chaudhari, R Cardenas-Zuniga, T Schubert, ... Journal of the American Chemical Society 143 (20), 7655-7670, 2021 | 37 | 2021 |
| Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum S Oncul, P Amero, C Rodriguez-Aguayo, GA Calin, AK Sood, ... RNA biology 17 (11), 1523-1534, 2020 | 28 | 2020 |
| Explainable artificial intelligence reveals novel insight into tumor microenvironment conditions linked with better prognosis in patients with breast cancer D Chakraborty, C Ivan, P Amero, M Khan, C Rodriguez-Aguayo, ... Cancers 13 (14), 3450, 2021 | 27 | 2021 |
| Targeting miRNAs and other non-coding RNAs as a therapeutic approach: an update E Bayraktar, R Bayraktar, H Oztatlici, G Lopez-Berestein, P Amero, ... Non-coding RNA 9 (2), 27, 2023 | 26 | 2023 |
| Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer AM Elsayed, P Amero, SA Salama, AH Abdelaziz, G Lopez-Berestein, ... Cancers 12 (9), 2406, 2020 | 22 | 2020 |
| Blockade of CDK7 reverses endocrine therapy resistance in breast cancer YM Attia, SA Shouman, SA Salama, C Ivan, AM Elsayed, P Amero, ... International journal of molecular sciences 21 (8), 2974, 2020 | 20 | 2020 |
| Recent insights into the nutritional immunomodulation of cancer‐related microRNAs TÖ Şahin, B Yılmaz, N Yeşilyurt, D Cicia, A Szymanowska, P Amero, ... Phytotherapy Research 37 (10), 4375-4397, 2023 | 19 | 2023 |
| Identification of an interfering ligand aptamer for EphB2/3 receptors P Amero, CL Esposito, A Rienzo, F Moscato, S Catuogno, V De Franciscis nucleic acid therapeutics 26 (2), 102-110, 2016 | 18 | 2016 |
| PRKAR1B-AS2 long noncoding RNA promotes tumorigenesis, survival, and chemoresistance via the PI3K/AKT/mTOR pathway AM Elsayed, E Bayraktar, P Amero, SA Salama, AH Abdelaziz, RS Ismail, ... International journal of molecular sciences 22 (4), 1882, 2021 | 17 | 2021 |
| Aptamers: Novel therapeutics and potential role in neuro-oncology P Amero, S Khatua, C Rodriguez-Aguayo, G Lopez-Berestein Cancers 12 (10), 2889, 2020 | 17 | 2020 |
| Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L CJ LaFargue, P Amero, K Noh, LS Mangala, Y Wen, E Bayraktar, ... Nature communications 14 (1), 2407, 2023 | 9 | 2023 |
| Rational combination of CRM1 inhibitor selinexor and olaparib shows synergy in ovarian cancer cell lines and mouse models KF Handley, C Rodriguez-Aguayo, S Ma, E Stur, R Joseph, E Bayraktar, ... Molecular cancer therapeutics 20 (12), 2352-2361, 2021 | 6 | 2021 |
| Combination of EphA2-and Wee1-Targeted Therapies in Endometrial Cancer SK Dasari, R Joseph, S Umamaheswaran, LS Mangala, E Bayraktar, ... International journal of molecular sciences 24 (4), 3915, 2023 | 5 | 2023 |
